Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Declines By 63.2%

Aethlon Medical, Inc. (NASDAQ:AEMD) saw a large drop in short interest in the month of August. As of August 31st, there was short interest totalling 227,800 shares, a drop of 63.2% from the August 15th total of 619,300 shares. Based on an average daily volume of 2,950,000 shares, the days-to-cover ratio is presently 0.1 days.

Aethlon Medical Trading Up 4.5 %

NASDAQ:AEMD opened at $0.39 on Friday. The stock has a 50-day moving average price of $0.39 and a 200 day moving average price of $0.88. The stock has a market capitalization of $5.48 million, a P/E ratio of -0.08 and a beta of 1.72. Aethlon Medical has a 12-month low of $0.24 and a 12-month high of $2.93.

Aethlon Medical (NASDAQ:AEMD) last announced its quarterly earnings data on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.10. During the same quarter in the previous year, the business earned ($1.30) EPS. On average, research analysts predict that Aethlon Medical will post -1.1 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AEMD has been the topic of several analyst reports. StockNews.com assumed coverage on Aethlon Medical in a research report on Friday. They set a “sell” rating on the stock. HC Wainwright lowered their target price on shares of Aethlon Medical from $10.00 to $7.00 and set a “buy” rating on the stock in a research note on Monday, June 24th.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.